Tier 2 — strong

Decreased serum betaine concentrations in patients after bariatric surgery

Tomasz Sledzinski, Elzbieta Goyke, Ryszard Tomasz Smolenski, Zbigniew Sledzinski, Julian Swierczynski
Obesity surgery 2011 21(10):1634-1639

Bibliography

PubMed
PMID 21618064
DOI
10.1007/s11695-011-0451-9
Funding
Funding was not specified in the indexed record or accessible funding metadata.
Competing interests
A competing-interest declaration was not available in the indexed record or accessible disclosure metadata.

Study snapshot

DesignBefore-and-after patient study
ModelHuman participants
Sample16 bariatric-surgery patients and 10 healthy controls
InterventionMeasured betaine status and related metabolites; no randomized TMG treatment
DurationBefore and 6 months after surgery
EndpointsBariatric surgery; Betaine status; Homocysteine

What the study showed, in plain terms

Published in 2011, this source examined human observational and biomarker research. Design: Before-and-after patient study. Sample/model: 16 bariatric-surgery patients and 10 healthy controls. The exposure or intervention was Measured betaine status and related metabolites; no randomized TMG treatment. Follow-up or treatment period: Before and 6 months after surgery.

Serum betaine fell after surgery while homocysteine remained elevated. The authors proposed testing supplementation, which this study did not do.

Observational exposure analysis: residual confounding and reverse causation remain possible. Associations do not establish that betaine supplementation causes the same outcome.

Continue with TMG Data Center

Continue with TMG Supplement: Trimethylglycine Benefits, Uses and Evidence

Key findings

  • Serum betaine fell after surgery while homocysteine remained elevated.
  • The authors proposed testing supplementation, which this study did not do.
  • The recorded outcome domains were Bariatric surgery; Betaine status; Homocysteine.
  • The result applies to the tested exposure: Measured betaine status and related metabolites; no randomized TMG treatment; Before and 6 months after surgery.

What this study can and cannot tell us

  • Observational exposure analysis: residual confounding and reverse causation remain possible. Associations do not establish that betaine supplementation causes the same outcome.
  • An individual controlled trial must be interpreted alongside its comparator, sample size, endpoint selection and independent replication. It does not validate a different commercial formulation or a general longevity claim.
  • Source basis: Indexed abstract and bibliographic data. Missing method details, funding information or participant denominators are not inferred.

Related papers in the corpus

Tier 4
Dietary Choline and Betaine and Risk of CVD: A Systematic Review and Meta-Analysis of Prospective Studies
Katie A Meyer et al. · Nutrients · 2017
Tier 4
Dietary Choline and Betaine Are Not Associated With the Risk of Type 2 Diabetes. A Systematic Review and Meta-Analysis of Observational Studies
Elham Sharifi-Zahabi et al. · Journal of diabetes research · 2026
Tier 4
Association of choline and betaine with the risk of cardiovascular disease and all-cause mortality: Meta-analysis
Qinglin Yang et al. · European journal of clinical investigation · 2023
Tier 4
Association of choline and betaine levels with cancer incidence and survival: A meta-analysis
Jiyoung Youn et al. · Clinical nutrition (Edinburgh, Scotland) · 2019

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Dr. Khaled Mahmoud, MBBChCritical Care Medicine, Longevity Science & Editorial Direction Dr. Amr Yasser, PhDCardiometabolic, Musculoskeletal, Gut & Bioavailability Dr. Abdulla Mostafa, PhDCellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology